Our History
Genetic services were first set up by Professor David Danks in the late 1960's,
commencing as a clinic of The Royal Children's Hospital. At this time the main service
related to clinical diagnosis and recurrence risk counselling for couples who had
a child with a serious birth defect or a genetic disorder. A newborn screening program
was set up to screen for phenylketonuria (from 1965) and hypothyroidism (from 1977).
Screening for cystic fibrosis was added later (in 1989). There was growing knowledge
about metabolic disorders (disturbances of body chemistry) and chromosome testing
was available.
In the early 1970's, Genetics moved into the area of obstetrics with the advent
of ultrasound and options for prenatal diagnosis: amniocentesis from 1994 and chorion
villous sampling from 1985. Dr John Rogers was instrumental in setting up clinical
services. Genetic services were established in obstetrics hospitals, where the medical
geneticists (most often paediatricians trained in clinical genetics) worked in collaboration
with obstetricians who performed the diagnostic procedures and provided obstetric
care. Carrier testing became available for a small number of disorders and aimed
to identify those at risk of having affected children.
The Victorian Clinical Genetics Services (VCGS) was established in 1988 with dedicated
funding from the Department of Human Services. The laboratory research activities
in genetics became consolidated in the newly established Murdoch Institute for Research
into Birth Defects with seed funding from the Murdoch family under the patronage
of Dame Elisabeth Murdoch. The VCGS expanded its clinical services to other metropolitan
hospitals and later to non-metropolitan centres. By 2000 there were clinics in 10
metropolitan and 10 regional centres.
Following the retirement of Professor Danks and the appointment of Professor Bob
Williamson as Executive Director of the VCGS and Director of the Murdoch Intitute,
with rapid expansion of services and staff, and with funding from the Department
of Human Services and the Murdoch family new office space was refurbished and officially
opened in 1998. An external review of the VCGS commended the VCGS on the high quality
of our services. Dr Stephen Kahler was appointed Clinical Director in 1998. The
advent of gene testing in the 1990's created possibilities for predictive testing
for adult onset disorders in neurogenetics and cancer genetics and Preimplantation
Genetic Diagnosis (PGD). Genetic Services became increasingly relevant to the adult
community and had broader utilization in reproductive genetics.
Diagnostic laboratory services evolved with time. First the Royal Children's Hospital
cytogenetic service came under the umbrella of the VCGS in 1986, newborn screening
in 1990 and maternal serum screening laboratory was established in 1996. The Molecular
genetic diagnostic services evolved from the research activities of Murdoch Childrens
Research Institute as did more recently, the mitochondrial enzymology.diagnosis,
which provides testing for Australasia. Significant changes occurred in 2000 in
the cytogenetic and metabolic laboratories.
The year 2000 was a time of change. The Murdoch Institute merged with The Children's
Hospital Research Institute to become the Murdoch Childrens Research Institute.
The metabolic screening laboratory came under the management of the VCGS and the
cytogenetic laboratory of The Royal Women's Hospital and the VCGS cytogenetic lab
amalgamated under the VCGS.
A VCGS Retreat led to the appointment of
Professor Agnes Bankier as l Director of the VCGS in September 2000. A new
management structure was put in place which shares the operational structure of
the Murdoch Childrens Research Institute through their common Chief Operations Officer,
Anne Cronin.
The Clinical activities of the VCGS started to operate as Genetic Health Services
Victoria in 2001 as part of a promotional campaign to improve accessibility of our
services and the diagnostic laboratories became known as VCGS Pathology in 2005.